The dexamethasone suppression test in depressive illness: clinical correlates.
D003866:Depressive Disorder / Q000175:diagnosis* / Q000188:drug therapy / Q000523:psychology; D003891:Desipramine / Q000627:therapeutic use; D003907:Dexamethasone; D003937:Diagnosis, Differential; D004311:Double-Blind Method; D004316:Doxepin / Q000627:therapeutic use; D004565:Electroconvulsive Therapy; D005260:Female; D006801:Humans; D006854:Hydrocortisone / Q000097:blood; D007099:Imipramine / Q000627:therapeutic use; D008297:Male; D008803:Mianserin / Q000627:therapeutic use; D008875:Middle Aged; D009661:Nortriptyline / Q000627:therapeutic use; D010624:Phenelzine / Q000627:therapeutic use; D011569:Psychiatric Status Rating Scales; D012642:Selegiline / Q000627:therapeutic use
D004316:Doxepin; D008803:Mianserin; D012642:Selegiline; D003907:Dexamethasone; D009661:Nortriptyline; D010624:Phenelzine; D007099:Imipramine; D003891:Desipramine; D006854:Hydrocortisone